SLQT NYSE
SelectQuote, Inc.
1W: +3.1%
1M: -22.0%
3M: -49.0%
YTD: -69.9%
1Y: -79.0%
3Y: -65.3%
5Y: -96.9%
$0.41
-0.02 (-3.54%)
Weekly Expected Move ±8.3%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
22 relationships22
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2025-02-10
Earliest Filing
2025-02-28
Latest Filing
partner: 18
investor: 4
Counterparties (Filed by SLQT)
22 relationshipsCompanies named in SLQT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Morgan Stanley | MS-PL | investor | Lead investor purchasing Senior Non-Convertible Preferred Stock and warrants | 2025-02-28 | View |
| Bain Capital | BCSF | investor | Lead investor purchasing Senior Non-Convertible Preferred Stock and warrants | 2025-02-28 | View |
| Newlight Partners LP | — | partner | Private equity firm where appointed director Srdjan Vukovic is a partner | 2025-02-28 | View |
| Soros Fund Management | — | partner | Private equity firm where appointed director Srdjan Vukovic previously worked | 2025-02-28 | View |
| Merrill Lynch | IPB | partner | Financial services firm where appointed director Srdjan Vukovic previously worked as an analyst | 2025-02-28 | View |
| Zing Health | — | partner | Private health insurance company where appointed director Srdjan Vukovic serves on the board | 2025-02-28 | View |
| Jade Health | — | partner | Service provider to behavioral health companies where appointed director Srdjan Vukovic serves on the board | 2025-02-28 | View |
| Oak Street Health | — | partner | Publicly traded primary care provider where appointed director Srdjan Vukovic previously served on the board | 2025-02-28 | View |
| CVS | CVS | partner | Acquirer of Oak Street Health | 2025-02-28 | View |
| Zenium Data Centers | — | partner | Company where appointed director Srdjan Vukovic previously served on the board | 2025-02-28 | View |
| CyrusOne | CONE | partner | Acquirer of Zenium Data Centers | 2025-02-28 | View |
| Heritage Insurance Holdings, Inc. | HRTG | partner | Publicly traded company that acquired Narragansett Bay Insurance Company | 2025-02-28 | View |
| Bain Capital Insurance | — | partner | Insurance firm where appointed director Christopher Wolfe is a Managing Director | 2025-02-28 | View |
| DFB Healthcare Acquisitions Corp. | — | partner | Publicly-traded SPAC where appointed director Christopher Wolfe was CFO | 2025-02-28 | View |
| Capital Z Partners | — | partner | Private equity fund where appointed director Christopher Wolfe previously worked | 2025-02-28 | View |
| Enhance Health | — | partner | Privately-held health insurance distributor where appointed director Christopher Wolfe serves on the board | 2025-02-28 | View |
| Permanent General Corp. | — | partner | Direct-to-consumer insurer where appointed director Christopher Wolfe previously served on the board | 2025-02-28 | View |
| Universal American Financial Corp. | — | partner | Medicare Advantage-focused insurer where appointed director Christopher Wolfe previously served on the board | 2025-02-28 | View |
| NL Monarch Holdings LLC | — | investor | Lead investor purchasing Senior Non-Convertible Preferred Stock and warrants | 2025-02-10 | View |
| NL Monarch Holdings II LLC | — | investor | Lead investor purchasing Senior Non-Convertible Preferred Stock and warrants | 2025-02-10 | View |
| MS Capital Partners Adviser Inc. | — | partner | Counterparty to Director Designation Agreement | 2025-02-10 | View |
| BCIS Monarch Investor, L.P. | — | partner | Counterparty to Director Designation Agreement | 2025-02-10 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-25 | Earnings Release; Exhibits | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-03-25 | Delisting Notice; Regulation FD; Exhibits | View | |
| 2026-02-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-12 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2025-11-14 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-21 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-21 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-29 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-07-02 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-28 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
| 2025-02-10 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of | Agreement | View |
| 2024-11-18 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-11-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-18 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2024-10-16 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2024-09-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-02-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR